Further to the post below re Ken Harvey’s concerns about Sigma, cruises, and product promotion….the ceo of the Generic Medicines Industry Association, Kate Lynch, has advised Harvey that:
“…under the requirements of the Therapeutic Goods Act (1989), the Therapeutic Goods Advertising Code (2007) and as stipulated in the Therapeutic Good Administration’s letter of marketing approval, Sponsor promotionof all prescription products (whether member or non-member) is required to comply with the requirements of the Medicines Australia code of conduct. Members of the Generic Medicines Industry Association are required to comply with the Medicines Australia code of conduct.”
More info here also.
Harvey adds: “What is interesting is that Sigma is a GMiA member. Given the above, I don’t see how Sigma can wiggle out of this one!”
Meanwhile, Medicines Australia has advised Harvey that it expects Sigma will decline to appear before its code of conduct committee…
Just for the record, Sigma has told the pharma industry news service, Pharma in Focus, that the cruise has nothing to do with promoting medicines and that suggestions to the contrary are “completely false”.
Sigma CEO Elmo de Alwis told the publication that the trip was a networking and educational opportunity for doctors, many of whom had attended previous cruises put together by the company – although he did acknowledge that the event gave company reps better access to GPs…